Dosimetry Analysis of 177Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial

By afschroeder • April 3, 2026

Ells Z, Meyer C, Kimura K, Wilhalme H, Cao M, Ludwig VB, Unterrainer LM, Sennung D, Nabong R, Felix C, Valle LF, Daley A, Czernin J, Dahlbom M, Kishan AU, Calais J. Dosimetry Analysis of ¹⁷⁷Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial. J Nucl Med. 2026 Apr 2:jnumed.125.271467. doi: 10.2967/jnumed.125.271467. Epub ahead of print. PMID: 41927282.

Tags: 177Lu, 177Lu-PSMA-I&T, Cardiology/Epi, DOM STAT, dosimetry, General Internal Medicine, oligorecurrent, prostate cancer, PSMA, Publications, SBRT, theranostics

CT Emphysema and Deep Learning-derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA

Ghotbi E, Hathaway QA, Jannatdoust P, Hadidchi R, Bancks MP, Bluemke DA, Budoff M, Post W, Hoffman EA, Smith BM, Lima JAC, Barr RG, Demehri[...]

CalShock: beyond the shock team, building on California’s cardiogenic shock system of care

Bell FM, Holtzman JN, Chandrakumar HP, Marogi EP, Khedraki R, Cheng R, Elliott A, Hilliard AA, Itchhaporia D, Chonde MD, Naidu SS, Egrie G, Mahmud[...]

Predictors of bleeding-related in-hospital complications after coronary angiography and percutaneous coronary intervention: A single-center retrospective cohort study in Iran

Andishmand A, Soltani MH, Mohammadi H, Namayandeh SM, Peigan P, Budoff M, Azimizadeh M, Andishmand M, Andishmand M. Predictors of bleeding-related in-hospital complications after coronary[...]